A randomized study comparing yttrium‐90 ibritumomab tiuxetan (Zevalin) and high‐dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

Avichai Shimoni, Arnon Nagler(Tel Aviv University), Tzila Zwas(Sheba Medical Center), Paulina Patachenko(Wolfson Medical Center), Jacob M. Rowe(Technion – Israel Institute of Technology), Irit Avivi(Tel Aviv Sourasky Medical Center), Moshe Yeshurun, Abraham Avigdor(Sheba Medical Center), Itai Levi(Soroka Medical Center), Reuven Or(Hebrew University of Jerusalem)
Cancer
January 17, 2012
10.1002/cncr.27418
Cited by 108

Related Papers

Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
|Blood|1998|1.9k
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
|Blood|1998|1.8k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859